Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+1.58M
-
Total reported value, excl. options
-
$918M
-
Value change
-
+$53.8M
-
Put/Call ratio
-
1.08
-
Number of buys
-
85
-
Number of sells
-
-77
-
Price
-
$33.77
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q1 2024
207 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q1 2024.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.7M shares), BlackRock Inc. (2.74M shares), STATE STREET CORP (1.96M shares), ARK Investment Management LLC (1.69M shares), VANGUARD GROUP INC (1.39M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.28M shares), Nikko Asset Management Americas, Inc. (1.28M shares), DIMENSIONAL FUND ADVISORS LP (1.1M shares), Woodline Partners LP (914K shares), and MORGAN STANLEY (868K shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.